https://biotechmorning.com/news/intellia-first-in-vivo-crispr-fda-filing Biotech Morning en 2026-04-27T14:14:15.183Z One Shot to Rewrite Your DNA: The Race for the First In Vivo CRISPR Approval https://biotechmorning.com/news/lilly-ajax-therapeutics-jak-inhibitor-deal Biotech Morning en 2026-04-27T14:13:27.213Z Lilly Just Dropped $2.3 Billion on a Drug With Zero Human Data https://biotechmorning.com/news/oricell-110m-car-t-solid-tumors Biotech Morning en 2026-04-27T14:12:44.344Z The $110M Bet That CAR-T Can Finally Beat Solid Tumors https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition Biotech Morning en 2026-04-27T14:12:02.395Z Gilead Just Dropped $5 Billion on a Munich Startup You've Never Heard Of https://biotechmorning.com/news/neurocrine-soleno-prader-willi-acquisition-2 Biotech Morning en 2026-04-27T14:11:19.448Z Neurocrine Just Bet $2.9 Billion on a Disease Most People Have Never Heard Of https://biotechmorning.com/news/ucb-neurona-cell-therapy-epilepsy-deal Biotech Morning en 2026-04-27T14:10:39.022Z UCB Just Bet $1.15 Billion That Brain Cells Can Cure Seizures https://biotechmorning.com/news/kidney-drug-filspari-fsgs-fda-approval Biotech Morning en 2026-04-27T14:09:54.445Z The Kidney Drug That Wasn't Supposed to Get Approved https://biotechmorning.com/news/lilly-foundayo-slow-launch-wall-street-panic Biotech Morning en 2026-04-27T14:09:14.532Z Lilly's Obesity Pill Got 1,390 Prescriptions in a Week. Wall Street Panicked. https://biotechmorning.com/news/uk-biotech-cash-no-ipos Biotech Morning en 2026-04-27T14:08:25.683Z UK Biotech Has Plenty of Cash. So Why Won't Anyone Go Public? https://biotechmorning.com/news/akt-pathway-108m-bet-terremoto Biotech Morning en 2026-04-27T14:07:45.418Z The Cancer Pathway Everyone Gave Up On Just Got a $108M Bet https://biotechmorning.com/news/generate-biomedicines-ipo-ai-drug-design Biotech Morning en 2026-04-26T14:11:42.460Z The $400M Bet That AI Can Design Better Drugs Than Humans https://biotechmorning.com/news/roche-oral-ms-pill-fenebrutinib Biotech Morning en 2026-04-26T14:11:00.100Z Roche Wants to Replace Your MS Infusion With a Tiny Pill https://biotechmorning.com/news/fda-cms-rapid-pathway-breakthrough-devices Biotech Morning en 2026-04-26T14:10:09.912Z The FDA Just Killed the Worst Wait in Medicine https://biotechmorning.com/news/fda-peptide-reclassification-compounding-pharmacies Biotech Morning en 2026-04-26T14:09:32.398Z The FDA Just Opened the Door for Peptide Pharmacies. Now What? https://biotechmorning.com/news/avalyn-pharma-200m-ipo-inhaled-lung-therapy Biotech Morning en 2026-04-26T14:08:51.618Z A $200M Bet That Breathing Your Medicine Beats Swallowing It https://biotechmorning.com/news/revolution-medicines-kras-undruggable-aacr-2026 Biotech Morning en 2026-04-26T14:08:04.368Z The 40-Year Quest to Drug Cancer's Most Stubborn Target May Finally Be Over https://biotechmorning.com/news/roche-nvidia-ai-factory-pharma Biotech Morning en 2026-04-26T14:07:15.623Z Roche Just Built Pharma's Biggest AI Brain. Here's Why It Matters.